Qtron Investments LLC Jazz Pharmaceuticals PLC Transaction History

Qtron Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $290,854 - $335,244	2,525 Added 85.97%	5,462 $657,000
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $129,686 - $154,464	-1,063 Reduced 26.58%	2,937 $380,000
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $228,826 - $281,975	1,764 Added 78.89%	4,000 $637,000
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $283,055 - $360,398	2,236 New	2,236 $298,000
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $469,793 - $674,853	-3,652 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $77,390 - $90,777	550 Added 17.73%	3,652 $603,000
Q3 2020 Nov 12, 2020	BUY	$105.46 - $144.13 $97,023 - $132,599	920 Added 42.16%	3,102 $442,000
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $208,773 - $265,942	2,182 New	2,182 $241,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.